Position in AZN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$656,464
-$2,053 QoQ
Shares Held
3,462
+3.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#780
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NorthRock Partners, LLC holds $45,176,274 across 12 Drug Manufacturers - General names. AZN ranks #6 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
66,702 | $16,784,891 | |
| 2 | JNJ |
Johnson & Johnson
|
36,605 | $9,296,571 | |
| 3 | LLY |
ELI LILLY & Co
|
7,302 | $8,758,238 | |
| 4 | MRK |
Merck & Co., Inc.
|
36,249 | $4,657,996 | |
| 5 | AMGN |
Amgen Inc
|
6,203 | $2,246,230 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
3,462 | $656,464 | |
| 7 | NVO |
Novo Nordisk A S
|
12,559 | $602,078 | |
| 8 | PFE |
Pfizer Inc
|
24,805 | $597,304 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $656,464 | 3,462 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $658,517 | 3,339 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||